





Annex I  
 
  United Nations system common position supporting the 
implementation of the international drug control policy 
through effective inter-agency collaboration 
 
 
  Shared principles  
 
 Reiterating our strong commitment to supporting Member States in developing 
and implementing truly balanced, comprehensive, integrated, evidence-based, human 
rights-based, development-oriented and sustainable responses to the world drug 
problem, within the framework of the 2030 Agenda for Sustainable Development, we, 
the members of the United Nations system, underlining the importance of the 
following common values:  
 • Commit to supporting the practical implementation of the outcome document of 
the special session of the General Assembly on the world drug problem, held in 
April 2016, General Assembly resolution S-30/1, entitled “Our joint 
commitment to effectively addressing and countering the world drug problem”, 
as a blueprint for action, charting a path that promotes more effective and 
humane drug control policies, supporting the commitment made in the context 
of the Sustainable Development Goals to leave no one behind;  
 • Recognize that the world drug problem is complex and multifaceted and that 
challenges posed by drugs have wide-ranging adverse impacts on security, 
human rights and development; 
 • Underscore that the multifaceted nature of the problem requires a 
comprehensive approach that includes law enforcement efforts ensuring 
people’s security and efforts promoting health, human rights, including equality 
and non-discrimination, and sustainable development; 
 • Commit to promoting a truly evidence-based and balanced approach, whereby 
sufficient attention is given to measures that address the root causes of drug 
abuse and cultivation and other involvement in the drug trade;  
 • Acknowledge that we have a common and shared responsibility to work 
together, in particular through the Commission on Narcotic Drugs, to pursue a 
coordinated, balanced and comprehensive approach leading to evidence -based 
and sustainable solutions; 
 • Recognize that the concern for the health and welfare of humankind underpins 
the three international drug control conventions, which, together with other 
relevant international instruments, are the cornerstone of the international drug 
control system; 
 • Acknowledge that the conventions allow for sufficient flexibility for countries 
to design and implement national drug policies according to their priorities and 
needs, consistent with the principle of common and shared responsibility and 
applicable international law;  
 • Acknowledge that the international drug control conventions, international 
human rights treaties and other relevant instruments and the 2030 Agenda are 
complementary and mutually reinforcing. National drug control programmes, 
strategies and policies should be designed and implemented by States in 







  Scope and purpose 
 
 • To guide approaches across the United Nations system, stepping up efforts to 
ensure that no one is left behind; 
 • To inspire the planning and implementation of United Nations activities, 
including joint inter-agency activities;  
 • To speak with one voice and raise awareness of the multifaceted nature of the 
world drug problem.  
 
  Directions for action 
 
 In addition to ongoing efforts, we commit to harnessing synergies and 
strengthening inter-agency cooperation, making best use of the expertise within the 
United Nations system, to further enhance consistent sharing of information and 
lessons learned and the production of more comprehensive data on the impact of drug 
policies, including with a view to supporting the implementation of the 2030 Agenda.  
 We, therefore, commit to stepping up our joint efforts and supporting each other, 
inter alia: 
 • To support the development and implementation of policies that put people, 
health and human rights at the centre, by providing a scientific evidence -based, 
available, accessible and affordable recovery-oriented continuum of care based 
upon prevention, treatment and support, and to promote a rebalancing of drug 
policies and interventions towards public health approaches;  
 • To promote the increased investment in measures aimed at minimizing the 
adverse public health consequences of drug abuse, sometimes referred to as 
harm reduction, which reduce new HIV infections, improve health outcomes 
and deliver broader social benefits by reducing pressure on health-care and 
criminal justice systems;  
 • To ensure the provision of drug prevention, treatment, rehabilitation and general 
support services, including health care and social protection in prison settings, 
ensuring that they are equivalent to and that they provide continuity of care with 
those in the community;  
 • To ensure the respect for the dignity and human rights of people who use drugs in 
all aspects of drug and social policies, including providing equal access for people 
who use drugs to public services, including housing, health care and education;  
 • To call for universal health coverage for people with drug use disorders and for 
the positioning of drug use disorders as with other health conditions that should 
be included in the overall universal health coverage framework in national 
health systems;  
 • To enhance access to controlled medicines for legitimate medical and scientific 
purposes, including the relief of pain and treatment of drug dependence;  
 • To enhance international support for effective capacity-building in developing 
countries to support the implementation of all Sustainable Development Goals, 
including through North-South, South-South and triangular cooperation; 
 • To support the identification of prevalent, persistent and harmful psychoactive 
drugs, including new psychoactive substances, and their associated health risks, 
using global and regional agencies’ early warning and alert systems;  
 • To provide guidance and technical assistance to strengthen cross-border law 






 • To promote sustainable livelihoods through adequately-sequenced, well-funded 
and long-term development-oriented drug policies in rural and urban areas 
affected by illicit drug activities, including cultivation, production and 
trafficking, bearing in mind environmental protection and sustainability;  
 • To promote alternatives to conviction and punishment in appropriate cases, 
including the decriminalization of drug possession for personal use, and to 
promote the principle of proportionality, to address prison overcrowding and 
overincarceration by people accused of drug crimes, to support implementation 
of effective criminal justice responses that ensure legal guarantees and due 
process safeguards pertaining to criminal justice proceedings and ensure timely 
access to legal aid and the right to a fair trial, and to support practical measures 
to prohibit arbitrary arrest and detention and torture;  
 • To call for changes in laws, policies and practices that threaten the health and 
human rights of people;  
 • To promote measures aimed at reducing stigma and eliminating discrimination 
and achieving universal coverage of evidence-based prevention, treatment and 
rehabilitation;  
 • To cooperate to ensure human rights-based drug control and address impunity 
for serious human rights violations in the context of drug control efforts;  
 • To assist Member States in implementing non-discriminatory policies, including 
with regard to ethnicity, race, sex, language, religion or other status;   
 • To promote the active involvement and participation of civil society and local 
communities, including people who use drugs, as well as women and young people;  
 • To provide Member States with the evidence base necessary to make informed 
policy decisions and to better understand the risks and benefits of new 
approaches to drug control, including those relating to cannabis;  
 • To compile, analyse and produce data reflecting United Nations system-wide 
practices and lessons-learned in drug-related matters, and to produce system-
wide data and analysis, including in the light of the 2019 ministerial segment of 
the Commission on Narcotic Drugs and the advancement of the implementation 
of the 2030 Agenda. 
 
  Accountability and operationalization 
 
 We commit to supporting each other’s activities, within our mandates, and to 
delivering balanced, comprehensive, integrated, evidence-based, human rights-based, 
development-oriented and sustainable support to Member States in implementing 
joint commitments, including the operational recommendations contained in the 
outcome document of the special session of the General Assembly on the world drug 
problem held in 2016. 
 With a view to ensuring coherent efforts to realize the commitments set out in 
this common position and, in particular, coordinated data collection to promote the 
scientific, evidence-based implementation of international commitments,1 we hereby 
establish a United Nations system coordination task team, to be led by UNODC, and 
composed of interested United Nations system entities, including those with expertise 
in the collection of drug-related data, within the framework of the Secretary-
General’s Executive Committee. 
__________________ 
 1  Working in line with the principles governing international statistical activities ( E/CN.3/2006/13, 
annex), as endorsed by the Committee for the Coordination of Statisti cal Activities. 
